Postoperative radiotherapy for non-small cell lung cancer

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 9, 2016, Pages

  Burdett, Sarah ^a   Rydzewska, Larysa ^a   Tierney, Jayne F ^a   Fisher, David ^a   Parmar, Mahesh K B ^a   Arriagada, Rodrigo ^b   Pignon, Jean Pierre ^c   Le Pechoux, Cecile ^c   Arriagada, R ^c   Brichet, A H ^d   Lafitte, J J ^d   Fisher, D ^a   Girling, D J ^a   Stephens, R J ^a   Stewart, L A ^a   Dautzenberg, B ^e   Debevec, M ^f   Kovac, V ^f   Gregor, A ^g   Park, J H ^h   Piantadosi, S ⁱ   Pignon, J P ^c   Rocmans, P ^j   Souhami, R ^k   Torri, V ^l   Van Houtte, P ^m   Trodella, L ⁿ   Wang, M ^o   more..

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e Groupe d'Etude et de Traitement des Cancers Bronchiques (GETCB)   (France)

^f INSTITUTE OF ONCOLOGY   (Slovenia)

^g EORTC DATA CENTER   (Belgium)

^h Korea Animal Cancer Center   (South Korea)

ⁱ Lung Cancer Study Group   (United States)

^j SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^m JULES BORDET INSTITUTE   (Belgium)

ⁿ CATHOLIC UNIVERSITY   (Italy)

^o PEKING UNION MEDICAL COLLEGE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LUNG SURGERY; META ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; SYSTEMATIC REVIEW; AGE; BIBLIOGRAPHIC DATABASE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCERLIT; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; DISTANT RECURRENCE FREE SURVIVAL; EVIDENCE BASED PRACTICE; HISTOPATHOLOGY; INTENTION TO TREAT ANALYSIS; LYMPH NODE METASTASIS; MEDLINE; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE RADIOTHERAPY; RANDOMIZATION; SEX;

EID: 84989213465     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002142.pub3     Document Type: Review

References (38)

1. van Houtte P, Rocmans P, Smets P, Goffin JC, Lustman-Marecal J, Vanderhoeft P, et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. International Journal of Radiation, Oncology, Biology and Physics 1980;6:983-6.
2. Feng QF, Wang M, Wang LJ, Yang ZY, Zhang YG, Zhang DW, et al. A study of postoperative radiotherapy in patients with non-small cell lung cancer: a randomized trial. International Journal of Radiation Oncology, Biology, Physics 2000;47(4):925-9.
3. EORTC 08861(unpublished). Phase III randomised trial of adjuvant radiotherapy vs no adjuvant therapy with completely resected non-small cell lung cancer.
4. Dautzenberg B, Arriagada R, Chammard AB, Jarema A, Mezzetti M, Mattson K, et al. for the Groupe d'Etude et de Traitement des Cancers Bronchiques. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer 1999; Vol. 86, issue 2:265-273.
5. Dautzenberg B, Arriagada R, Chammard AB, Jarema A, Mezzetti M, Mattson K, et al. for the Groupe d'Etude et de Traitement des Cancer Bronchiques. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer 1999;86(2):265-73; Vol. 86, issue 2:265-273.
6. Trodella L, Granone P, Valente S, Valentini V, Balducci M, Mantini G, et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomised trial. Radiotherapy and Oncology 2002;62:11-9.
7. Park JH. Postoperative adjuvant therapy for stage IIIa non-small cell lung cancer. Journal of Thoracic Oncology 2007;2 (8 Suppl 4):S651.
8. Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. New England Journal of Medicine 1986;315(22):1377-81.
9. Lafitte JJ, Ribet ME, Prévost BM, Gosselin BH, Copin M-C, Brichet AH. Post-irradiation for T2 N0 M0 non-small cell carcinoma: a prospective randomized study. Annals of Thoracic Surgery 1996;62:830-4.
10. Stephens RJ, Girling DJ, Bleehen NM, Moghissi K, Yosef HMA, Machin D. The role of post-operative radiotherapy in non-small cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. British Journal of Cancer 1996;74:632-9.
11. Debevec M, Bitenc M, Vidmar S, Rott T, Orel J, Strojan P, et al. Post-operative radiotherapy for radically resected N2 non-small cell lung cancer: randomised clinical study 1988-92. Lung Cancer 1996;14:99-107.
12. Mayer R, Smolle-Juettner F-M, Szolar D, Stuecklschweiger GF, Quehenberger F, Friehs G, et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 1997;112:954-9.
13. Dymek P, Kowalska T, Reinfuss M, Walasek T, Zareba-Szlubowska M, Mitus J, et al. The efficacy of adjuvant thoracic radiation therapy in NSCLC patients with ipsilateral mediastinal/hilar lymph node involvement [Ocena skutecznosci pooperacyjnej teleradioterapii chorych na NDRP zoperowanych miejscowo doszczetnie z obecnoscia przerzutow w usunietych wezlach chlonnych srodpiersia albo wneki (kontrolowane doswiadczenie kliniczne)]. Pneumonol Alergol Pol 2003;71(11-12):496-503.
14. Lung Cancer Study Group (Unpublished). Phase III randomised study of post-op radiotherapy vs no radiotherapy following resection of non-small cell lung cancer.
15. LUNG ART-IGR 2006/1202 (ongoing). Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement. NCT00410683.
16. American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society, 2007.
17. Billiet C, Dealuwe H, Peeters S, Vansteenkiste J, Dooms C, Haustermans K, et al. Corrigendum to "Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis". Radiotherapy and Oncology 2014;113(2):300-1.
18. Datta D, Lahiri B. Preoperative evaluation of patients undergoing lung resection surgery. Chest 2003;123:2096-103.
19. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG editor(s). Systematic Reviews. London: BMJ Publishing Group, 1995:17-36.
20. Fisher DJ, Copas AJ, Tierney JF, Parmar MKB. A critical review of methods for the assessment of patient-level interactions in individual patient data (IPD) meta-analysis of randomised trials, and guidance for practitioners. Journal of Clinical Epidemiology 2011;64:949-67.
21. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
22. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Handbook for Systematic Reviews of Interventions - Version 5.0.1 [updated in September 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
23. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011;61:69-90.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457-81.
25. Lefebvre C, Clarke MJ. Identifying randomised trials. In: Egger M, Smith GD, Altman DG editor(s). Systematic Reviews in Healthcare. 2nd Edition. London: BMJ Publishing Group, 2001:69-87.
26. Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group. Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons Ltd, 2008:95-150.
27. Mountain CF. The new international staging system for lung cancer. Surgical Clinics of North America 1987;67(5):925-35.
28. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111(6):1710-7.
29. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. British Medical Journal 1995;311(7010):899-909.
30. Parmar MKB, Machin D. Survival Analysis: A Practical Approach. London: John Wiley & Sons Ltd, 1995.
31. Patel SH, Ma Y, Wernicke AG, Nori D, Chao KSC, Parashar B. Evidence supporting contemporary post-operative radiation therapy (PORT) using linear accelerators in N2 lung cancer. Lung Cancer 2014;84:156-60.
32. The Cochrane Collaboration. Review Manager (RevMan). Version 5.3.5. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2014.
33. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Controlled Clinical Trials 1996;17(4):343-6.
34. StataCorp LP. StataCorp 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP, 2013.
35. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Progress in Cardiovascular Diseases 1985;27(5):335-71.
36. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352:257-63.
37. Burdett S, Stewart L, on behalf of the PORT Meta-analysis Trialist Group. Postoperative radiotherapy in non-small cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 2005;47(1):81-3.
38. Burdett S, Rydzewska L, Tierney JF, Fisher DJ. A closer look at the effects of postoperative radiotherapy by stage and nodal status: updated results of an individual participant data meta-analysis in non-small-cell lung cancer. Lung Cancer 2013;80:350-2.